44 PRIMECAP Management Insulet Trades
PRIMECAP Management acquired 425 Thousand Insulet shares worth $132 Million. That's 0.11% of their equity portfolio (120th largest holding). The first Insulet trade was made in Q1 2013. Since then PRIMECAP Management bought shares seven more times and sold shares on 36 occasions. The stake costed the investor $12.2 Million, netting the investor a gain of 981% so far.
News about Insulet Corporation and PRIMECAP Management
Insulet: An Interesting, Yet Expensive, Story
Insulet Corporation, the maker of Omnipod Insulin Management System, faces share pressure despite operational advancements. Learn more on PODD stock here.
Should You Invest in Insulet Corporation (PODD)?
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2022 investor letter....
Insulet: The Game-Changer In Diabetes Management (NASDAQ:PODD)
Insulet achieved another remarkable fiscal year, driven by the successful adoption of Omnipod 5, which is being used by growing diabetic patients globally. R...
Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod 5 Controller
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), today announced a Medical Device Correction for the Omnipod 5 Automated Insulin Delivery System ...